Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2430-2444
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2430
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2430
Characteristics | Overall | Training set | Testing set | P value |
n = 26922 | n = 18845 | n = 8077 | ||
Age | 44.00 (39.00, 47.00) | 44.00 (39.00, 47.00) | 44.00 (39.00, 47.00) | 0.730 |
LN examined | 19.00 (14.00, 27.00) | 19.00 (14.00, 27.00) | 19.00 (14.00, 27.00) | 0.959 |
LN positive | 1.00 (0.00, 4.00) | 1.00 (0.00, 4.00) | 1.00 (0.00, 4.00) | 0.800 |
LNR | 0.03 (0.00, 0.19) | 0.03 (0.00, 0.19) | 0.03 (0.00, 0.20) | 0.851 |
LODDS | -2.66 (-3.66, -1.29) | -2.66 (-3.61, -1.30) | -2.71 (-3.66, -1.24) | 0.881 |
Survival months | 51.00 (21.00, 105.00) | 51.00 (21.00, 106.00) | 50.00 (21.00, 103.00) | 0.169 |
Gender (%) | 0.856 | |||
Female | 13367 (49.7) | 9364 (49.7) | 4003 (49.6) | |
Male | 13555 (50.3) | 9481 (50.3) | 4074 (50.4) | |
Race (%) | 0.898 | |||
White | 19659 (73.0) | 13783 (73.1) | 5876 (72.7) | |
Blake | 4050 (15.0) | 2829 (15.0) | 1221 (15.1) | |
Others | 2985 (11.1) | 2073 (11.0) | 912 (11.3) | |
Unknown | 228 (0.8) | 160 (0.8) | 68 (0.8) | |
Marital status (%) | 0.383 | |||
Married | 15296 (56.8) | 10674 (56.6) | 4622 (57.2) | |
Others/unknown | 11626 (43.2) | 8171 (43.4) | 3455 (42.8) | |
Primary site (%) | 0.783 | |||
Right colon | 13053 (48.5) | 9139 (48.5) | 3914 (48.5) | |
Left colon | 13342 (49.6) | 9330 (49.5) | 4012 (49.7) | |
Large intestine, NOS | 527 (2.0) | 376 (2.0) | 151 (1.9) | |
Histology (%) | 0.995 | |||
Adenomas/adenocarcinomas | 23406 (86.9) | 16384 (86.9) | 7022 (86.9) | |
Cystic/mucinous/serous neoplasms | 3324 (12.3) | 2326 (12.3) | 998 (12.4) | |
Others | 192 (0.7) | 135 (0.7) | 57 (0.7) | |
Grade (%) | 0.055 | |||
Well | 2775 (10.3) | 1992 (10.6) | 783 (9.7) | |
Moderately | 18265 (67.8) | 12708 (67.4) | 5557 (68.8) | |
Poorly | 5094 (18.9) | 3603 (19.1) | 1491 (18.5) | |
Undifferentiated | 788 (2.9) | 542 (2.9) | 246 (3.0) | |
Stage (%) | 0.198 | |||
Stage 0 | 204 (0.8) | 136 (0.7) | 68 (0.8) | |
Stage I | 3939 (14.6) | 2792 (14.8) | 1147 (14.2) | |
Stage II | 7360 (27.3) | 5103 (27.1) | 2257 (27.9) | |
Stage III | 9806 (36.4) | 6914 (36.7) | 2892 (35.8) | |
Stage IV | 5613 (20.8) | 3900 (20.7) | 1713 (21.2) | |
T stage (%) | 0.437 | |||
T0 | 210 (0.8) | 142 (0.8) | 68 (0.8) | |
T1 | 2595 (9.6) | 1845 (9.8) | 750 (9.3) | |
T2 | 2801 (10.4) | 1985 (10.5) | 816 (10.1) | |
T3 | 15121 (56.2) | 10537 (55.9) | 4584 (56.8) | |
T4 | 6195 (23.0) | 4336 (23.0) | 1859 (23.0) | |
N stage (%) | 0.259 | |||
N0 | 12410 (46.1) | 8645 (45.9) | 3765 (46.6) | |
N1 | 7886 (29.3) | 5576 (29.6) | 2310 (28.6) | |
N2 | 6626 (24.6) | 4624 (24.5) | 2002 (24.8) | |
M stage (%) | 0.351 | |||
M0 | 21309 (79.2) | 14945 (79.3) | 6364 (78.8) | |
M1 | 5613 (20.8) | 3900 (20.7) | 1713 (21.2) | |
Size (%) | 0.871 | |||
< 5 cm | 9238 (34.3) | 6476 (34.4) | 2762 (34.2) | |
≥ 5 cm | 9179 (34.1) | 6434 (34.1) | 2745 (34.0) | |
Unknown | 8505 (31.6) | 5935 (31.5) | 2570 (31.8) |
- Citation: Xia HB, Chen C, Jia ZX, Li L, Xu AM. Advantage of log odds of positive lymph nodes in prognostic evaluation of patients with early-onset colon cancer. World J Gastrointest Surg 2023; 15(11): 2430-2444
- URL: https://www.wjgnet.com/1948-9366/full/v15/i11/2430.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i11.2430